Cyclopentylglycine (Cpg) is a competitive inhibitor of isoleucine uptake in E. coli [1] and also has been used in designing angiotensin II antagonists [2]. We exploited a commercially available chiral auxillary [3] to obtain Cpg. Thus, stereoselective alkylation of the enolate derived from benzyl (2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate (1) with cyclopentyl iodide afforded anti-␣-monosubstituted product, benzyl (2R,3S,5S)-(-)-6-oxo-2,3-diphenyl-5-cyclopentyl-4-morpholinecarboxylate (3) in 60% yield. Catalytic hydrogenolysis over PdCl 2 cleaved the auxiliary ring system to give L-cyclopentylglycine (4) in 84% yield. Subsequent protection of the ␣-amino function with Fmoc-OSu gave Fmoc-L-cyclopentylglycine (5) in high yield.[1] Harding, W.M.; Shire, W.J. J. Biol. Chem., 206, 401 (1954).[2] Nyeki, O.; Szalay, K.S.; Kisfaludy, L.; Karpati, E.; Szporny, L.;Makara, G.B.; Varga, B. Peptide chemistry has been a pioneer field in laboratory automation and high troughput parallel synthesis. Today, there is a growing need for high quality peptide, to successfully take advantage of the data generated by the human genome sequencing. From milligram scale and low purity requirements (immunology) to gram scale and high purity (diagnostic), there is a demand for high throughput automated synthesizers providing a high flexibility in terms of scales, protocols and reagents used. We will describe a new instrument able to synthesize up 80 peptides in parallel, scalable from 5 micromoles to 5 millimoles per reactor. Cleavage, sample preparation and HPLC injections can also be performed automatically.Using selected examples, this presentation will show how the instrument can meet different requirements in terms of scale, timing and purity, especially for long or difficult sequences. Typically, branched cyclic peptides analogs are synthesized starting from resin-bound cyclic skeletons with branched segments (strategy 1) requiring an anchorage point and high levels of orthogonal protection [1]. Our synthetic approach to branched cyclic analogs of AII starts by linking the branched segment of the cyclic peptide to the polymeric support (strategy 2) in order to simplify orthogonal protection schemes.
P C 338Poster Section C P 157 O-GLYCOPEPTIDE SYNTHESIS MADE EASY